Publicaciones en colaboración con investigadores/as de Karolinska Institute (29)

2023

  1. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

    Science translational medicine, Vol. 15, Núm. 712, pp. eabn5939

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  3. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

    JAMA, Vol. 330, Núm. 13, pp. 1266-1277

  4. Genetic Associations between Modifiable Risk Factors and Alzheimer Disease

    JAMA Network Open, Vol. 6, Núm. 5

  5. Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study

    Multiple Sclerosis Journal, Vol. 29, Núm. 14, pp. 1808-1818

  6. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

    European Journal of Preventive Cardiology, Vol. 30, Núm. 1, pp. 8-16

  7. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

    European heart journal, Vol. 44, Núm. 13, pp. 1157-1166

  8. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 36

  9. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 1, pp. 55-64